VAT Challenge For Hair Loss Replacement Systems – What Defines A “Disability”

Hair Loss Replacement Systems

Date:

Category:

Share this article:

The latest “health” related discussion in the VAT Tribunal reports this week related to whether a hair loss replacement system that a taxpayer had devised, could be treated as a Zero rated on the basis that it was a supply to a disabled person of the services of adapting goods to meet the needs of their health condition.

The taxpayer dealt with a range of clients including those who had suffered hair loss following medical treatments including chemotherapy. The service it offered, HMRC felt was different from what would be regarded as a wig. HMRC accept that wigs are regarded as eligible for zero rating when supplied to a person who is chronically sick or disabled – HMRC Public Notice 701/7

However, the hair loss system being offered by the taxpayer fell short of being regarded as a wig. A custom-made wig mask was fitted over the area of hair loss and fixed in place using existing hair but then added to with colour-matched fibre hair which was then styled to suit the client’s appearance. Not a wig in HMRC’s eyes, therefore.

It was then that the meaning of a “disabled” person was considered. Many clients had experienced hair loss as a result of cancer – a serious illness we’d all agree. Still, HMRC distinguished the cause of the hair loss from the hair loss itself, arguing that significant hair loss was not, of itself, a chronic illness.

The First Tier Tribunal fell behind HMRC’s arguments and accepted that, in the letter of the law, the service provided by the taxpayer was not a wig in itself and neither were their services the adaptation of goods (a wig) for a disabled person. Hair loss in isolation was not a disability, nor was it an impairment which affected the everyday activities that the person could undertake, was their view.

Many may well dispute that interpretation, in the same way that many see “cosmetic” health offerings contributing to an improvement in the mental health and general well-being of the individual. However, VAT case after case in the courts, evidences how specifically words and their meaning are to be interpreted and it is in the law that all cases must start – in this instance with the VAT Act, Sch 8 (Zero Rating Schedule), Group 12 (Drugs, Medicines, Aids for the Disabled)

Outside of the technical VAT arguments of the case, it should be noted that the taxpayer had sought VAT advice on the liability of the system that they had devised – which signposted them to the fact that wigs could qualify for zero-rating when supplied to a disabled person. However, this general advice seems not to have explored whether the offering the taxpayer made constituted a wig, or the adaptation of a wigs, and what defined a “disabled person”.

It’s important to have explored with your VAT adviser the full context of what you plan to supply, as this, as well as the nature of your client, can influence the VAT treatment that will be applied. The taxpayer in this instance had been issued with VAT assessments totalling £277,083.10 for the period from Jan 2018. A value that they are unlikely to be able to recover from those past clients.

A harsh ruling by the Tribunal some will say and – as a First Tier Case – it is open to appeal by the taxpayer. It shows, however, that VAT remains a tax of complexity and all clients need to be alert to challenges from HMRC as to how their supplies, especially in this area of health and wellbeing, are being treated.

Speak to an expert

If this case report raises any concerns then contact the Xeinadin Indirect Tax team using the form below.

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

If you opt for acceptance, we will place all cookies. If you opt for rejection, we will only place functional and analytical cookies. You can adjust your preferences at a later time.

Accept Reject More options

This website uses cookies

With these cookies, we and third parties can collect information about you and your internet behaviour, both within and outside our website. Based on this, we and third parties adjust the website, our communication, and advertisements to your interests and profile. You can read more information in our cookie statement.

Functional cookies
Arrow down

Functional cookies are essential for the proper functioning of our website. They allow us to enable basic functions such as page navigation and access to secure areas. These cookies do not collect personal information and cannot be disabled.

Analytical cookies
Arrow down

Analytical cookies help us gain insight into how visitors use our website. We collect anonymised data about page interactions and navigation, enabling us to continuously improve our site.

Marketing cookies
Arrow down

Marketing cookies are used to track visitors when they visit different websites. The goal is to display relevant advertisements to the individual user. By allowing these cookies, you help us show you relevant content and offers.

Accept all Save

Name

Subtitle
Developer
Location
They are focussed on creating a future-focused and relationship-driven culture, that keeps its promises to you, our team members, and partners.
Xeinadin